Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Impact of Berberine as an Adjunct Therapy on Hormonal, Metabolic, and Inflammatory Outcomes in Women Diagnosed with Polycystic Ovary Syndrome: A Retrospective Case-Control Analysis

  • By

  • Lingling Gao

  • Yuxin Ju

  • Yuanyuan Zhu

  • Jianbo Xu

  • Dan Lu

  • May 22, 2026

Share

Original Source(s)

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study

  • by Lingling Gao, Yuxin Ju, Yuanyuan Zhu, Jianbo Xu, Dan Lu

  • May 22, 2026

Related Content

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Prevalence and associated factors of gestational diabetes mellitus among women with polycystic ovary syndrome: a systematic review and meta-analysis

Is MAR Associated With Hormone‐Related Cancer Risk?

A target trial emulation found small excess risks following fertility treatment, although the observed as­sociations may largely reflect underlying infertility and increased medical surveillance.